Programmdetails

Postervorträge

Valve-in-Valve Prozeduren und Klappenthrombosen

Samstag, 6. April | 10:00 - 11:30 Uhr | Posterbereich 8

Vorsitz/Chair: Raffi Bekeredjian (Stuttgart), Tobias Zeus (Düsseldorf)

Agenda

(P2007)
Hämodynamische Funktion der ACURATE neo2 TAVI-Prothese bei Valve-in-Valve Prozeduren - Bench-testing Ergebnisse für 42 verschiedene ViV Szenarien
J. Curio (Köln)
(P2008)
Outcome of 100 Patients treated with Valve-in-Valve Transcatheter Aortic Valve Replacement at a High Volume Center
M. Paukovitsch (Ulm)
(P2009)
Prevalence and prognostic impact of aortic valve reintervention following TAVI: an analysis based on health-insurance claims in Germany
L. Waldschmidt (Hamburg)
(P2010)
Indications and Outcomes of Redo-TAVI for degenerated Transcatheter Heart Valves: Experience from a Single High-Volume Center in Germany
I. Richter (Leipzig)
(P2011)
Transcatheter electrosurgical leaflet splitting to prevent TAVI-induced coronary obstruction in stented vs. stentless bioprosthetic aortic valves: Results from the multicenter EURO-BASILICA registry
I. Richter (Leipzig)
(P2012)
Longterm outcome of bail-out ViV-TAVI in the same procedure
I. Horn (Bad Oeynhausen)
(P2013)
Comparison of two self-expanding transcatheter heart valves for degenerated surgical bioprostheses: The AVENGER multicenter registry
T. Rheude (München)
(P2014)
Response to anticoagulant treatment in clinical apparent thrombosis of transcatheter aortic valve replacement in a monocentric retrospective cohort
M. Geyer (Mainz)
(P2015)
Prädiktoren der Hämostase zur Detektion von subklinischen Klappenthrombosen nach Transkatheter-Aortenklappenersatz
D. Hesselbarth (Freiburg im Breisgau)
Diese Seite teilen